STRATEC SE (SRBZF)
148.00
0.00 (0.00%)
USD |
OTCM |
May 07, 16:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 1.799B |
| 52 Week High (Daily) | |
| 52 Week Low (Daily) | |
| All-Time High (Daily) | |
| Year to Date Total Returns (Daily) | |
| 1 Month Total Returns (Daily) | |
| 1 Year Total Returns (Daily) | 0.47% |
| Valuation | |
| PE Ratio | 183.42 |
| PE Ratio (Forward) | |
| PS Ratio | 5.857 |
| Price to Book Value | 6.455 |
| EV to EBITDA | |
| Dividend | |
|---|---|
| Dividend | 0.7024 |
| Dividend Yield (Forward) | |
| Financials | |
| Revenue (5 Year Growth) | |
| Revenue (Quarterly YoY Growth) | |
| EPS Diluted (5 Year Growth) | |
| EPS Diluted (Quarterly YoY Growth) | |
| Debt to Equity Ratio | 0.5568 |
| Return on Equity | |
| Return on Assets | |
| Risk | |
| Beta (5Y) | |
| Max Drawdown (5Y) | 0.86% |
Profile
| STRATEC SE engages in the design and manufacture of automated analyzer systems in the fields of clinical diagnostic and biotechnology. It operates through the following segments: Instrumentation, Diatron, Smart Consumables, and Other Activities. The Instrumentation segment consults, designs, develops and produces fully automated solutions for its partners in the fields of diagnostics including blood banking. The Diatron segment comprises the business with systems, system components, consumables and tests in the low throughput hematology and clinical chemistry segment. The Smart Consumables segment includes the business with developing and manufacturing smart consumables in the fields of diagnostics, life sciences, and medical technology. The Other Activities segment covers the development of work flow software for networking several analyzer systems and the development and sale of scientific materials and technologies. The company was founded by Hermann Leistner in 1979 and is headquartered in Birkenfeld, Germany. |
| URL | http://www.stratec.com |
| Investor Relations URL | N/A |
| HQ State/Province | Rheinland-Pfalz |
| Sector | Health Care |
| Industry | Health Care Equipment & Supplies |
| Next Earnings Release | May. 11, 2026 |
| Last Earnings Release | Nov. 07, 2025 |
| Next Ex-Dividend Date | Jun. 25, 2026 |
| Last Ex-Dividend Date | Jul. 01, 2025 |
Profile
| STRATEC SE engages in the design and manufacture of automated analyzer systems in the fields of clinical diagnostic and biotechnology. It operates through the following segments: Instrumentation, Diatron, Smart Consumables, and Other Activities. The Instrumentation segment consults, designs, develops and produces fully automated solutions for its partners in the fields of diagnostics including blood banking. The Diatron segment comprises the business with systems, system components, consumables and tests in the low throughput hematology and clinical chemistry segment. The Smart Consumables segment includes the business with developing and manufacturing smart consumables in the fields of diagnostics, life sciences, and medical technology. The Other Activities segment covers the development of work flow software for networking several analyzer systems and the development and sale of scientific materials and technologies. The company was founded by Hermann Leistner in 1979 and is headquartered in Birkenfeld, Germany. |
| URL | http://www.stratec.com |
| Investor Relations URL | N/A |
| HQ State/Province | Rheinland-Pfalz |
| Sector | Health Care |
| Industry | Health Care Equipment & Supplies |
| Next Earnings Release | May. 11, 2026 |
| Last Earnings Release | Nov. 07, 2025 |
| Next Ex-Dividend Date | Jun. 25, 2026 |
| Last Ex-Dividend Date | Jul. 01, 2025 |